Related Experiment Videos
New drugs in phase I and beyond workshop
1Pfizer Inc, Groton, CT 06340, USA.
Agents and Actions. Supplements
|January 1, 1995
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Demonstration of 24-hour continuous optical turbulence monitoring in a city.
Optics express·2025
Exploring atmospheric optical turbulence: observations across zenith angles.
Applied optics·2024
Identifying children with Cystic Fibrosis in population-scale routinely collected data in Wales: A Retrospective Review.
International journal of population data science·2021
Ro 45-2081, a TNF receptor fusion protein, prevents inflammatory responses in the airways.
Agents and actions. Supplements·1998
Immunomodulation of Crohn's disease by interleukin-10.
Agents and actions. Supplements·1998
Cartilage protective agent (CPA) Ro 32-3555, a new matrix metalloproteinase inhibitor for the treatment of rheumatoid arthritis.
Agents and actions. Supplements·1998
The complexity of the B7-CD28/CTLA-4 costimulatory pathway.
Agents and actions. Supplements·1998
A role for inflammatory cytokines in the productive activation of antigen-specific CD4+ T-cells.
Agents and actions. Supplements·1998
CD40 and its ligand in cell-mediated immunity.
Agents and actions. Supplements·1998
Evaluation of brexpiprazole as adjunctive therapy in treatment-resistant depression: Real-world data.
Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi·2026
Unveiling the sumatriptan dose-relief relationship.
European journal of clinical pharmacology·2026
Mapping Therapeutic Drug Monitoring Research in Low- and Middle-Income Countries: A Scoping Review (2015-2024).
Therapeutic drug monitoring·2026
Polymeric systems for peptide and protein delivery: design principles, translational barriers, and future research directions.
International journal of pharmaceutics·2026